» Authors » Inge Sokilde Pedersen

Inge Sokilde Pedersen

Explore the profile of Inge Sokilde Pedersen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 78
Citations 2260
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brenne S, Madsen P, Pedersen I, Hveem K, Skorpen F, Krarup H, et al.
BMC Cancer . 2024 Oct; 24(1):1251. PMID: 39385172
Background: Today, the prognostic tools available at the time of diagnosis in colorectal cancer (CRC) are limited. Better prognostic tools are a prerequisite for personalised treatment. This study aimed to...
2.
Parsons M, de la Hoya M, Richardson M, Tudini E, Anderson M, Berkofsky-Fessler W, et al.
Am J Hum Genet . 2024 Aug; 111(9):2044-2058. PMID: 39142283
The ENIGMA research consortium develops and applies methods to determine clinical significance of variants in hereditary breast and ovarian cancer genes. An ENIGMA BRCA1/2 classification sub-group, formed in 2015 as...
3.
Nanthan K, Pedersen I, Andersen D, Bor M
Acta Haematol . 2024 Aug; 147(5):564-570. PMID: 39140696
Introduction: Congenital fibrinogen disorders are a heterogenous group of fibrinogen defects. Case Presentation: Here, we describe hypodysfibrinogenemia in a 33-year-old female patient with provoked recurrent deep vein thrombosis (DVT) diagnosed...
4.
Krarup K, Riis J, Mork M, Nguyen H, Pedersen I, Kristensen S, et al.
Interact J Med Res . 2024 Jul; 13:e46570. PMID: 38976326
Background: Gaming has become an integrated part of life for children and adults worldwide. Previous studies on the impact of gaming on biochemical parameters have primarily addressed the acute effects...
5.
Mark L, Terp S, Krarup H, Thomassen M, Pedersen I, Bogsted M
Cancers (Basel) . 2023 Dec; 15(23). PMID: 38067337
Homologous recombination deficiency (HRD) can arise from germline or somatic pathogenic variants as well as other genomic damage and epigenetic alterations in the HR repair pathway. Patients with tumors presenting...
6.
Lildballe D, Frederiksen A, Schonewolf-Greulich B, Brasch-Andersen C, Lautrup C, Karstensen H, et al.
Eur J Med Genet . 2023 Nov; 66(12):104872. PMID: 37967791
Genetic conditions are often familial, but not all relatives receive counseling from the same institution. It is therefore necessary to ensure consistency in variant interpretation, counseling practices, and clinical follow...
7.
Terkelsen T, Hansen T, Herlin M, Djursby M, Nyegaard M, Pedersen I, et al.
Ugeskr Laeger . 2023 Oct; 185(39). PMID: 37873989
Polygenic risk scores (PRS) identify at-risk individuals for many common diseases. A discussion of strengths and limitations is carried out in this review. PRS complement traditional genetic testing and have...
8.
Nowicka-Matus K, Salkus G, Sonderkaer M, Pedersen I, Ernst A, Kubik M, et al.
JCO Precis Oncol . 2023 Aug; 7:e2300173. PMID: 37595182
No abstract available.
9.
Brenne S, Madsen P, Pedersen I, Hveem K, Skorpen F, Krarup H, et al.
Br J Cancer . 2023 Jul; 129(5):861-868. PMID: 37438612
Background: Colorectal cancer (CRC) is often diagnosed in advanced stages. Circulating tumour DNA (ctDNA) has been proposed as an early diagnostic biomarker. However, as a screening tool, ctDNA has mainly...
10.
Stubbe B, Larsen A, Madsen P, Krarup H, Pedersen I, Lundbye-Christensen S, et al.
Front Oncol . 2023 Jun; 13:1211292. PMID: 37333823
Introduction: Current prognostic blood-based biomarkers for pancreatic adenocarcinoma (PDAC) are limited. Recently, promoter hypermethylation of SFRP1 (phSFRP1) has been linked to poor prognosis in patients with gemcitabine-treated stage IV PDAC....